PharmaCyte Biotech, Inc.
3 private offerings reported to the SEC on Form D since 2016, $78.0M sold in all. Biotech, Nevada.
- Form D offerings: 3
- Reported sold: $78.0M
- Newest: Sep 4, 2025
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Sep 4, 2025 | โ | $7.0M | $7.0M | PharmaCyte Biotech, Inc.Biotech ยท Nevada | Not amended | 0001683168-25-006676 |
| Sep 1, 2021 | โ | $70.0M | $70.0M | PharmaCyte Biotech, Inc.Biotech ยท California | Not amended | 0001683168-21-004022 |
| Jan 19, 2016 | โ | $1.0M | $3.1M | PharmaCyte Biotech, Inc.Pharma ยท Maryland | Not amended | 0001019687-16-004862 |
- Ticker
- PMCB
- Business address
- Las Vegas, NV
- Incorporated in
- Nevada
- SEC industry
- Biological Products, (No Diagnostic Substances)
- Former names
- Nuvilex, Inc.; Efoodsafety Com Inc
- All SEC filings
- CIK 1157075 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR